Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk

Author(s):  Cabaleiro Joe

Issue:  Jan/Feb 2020 - Volume 24, Number 1
View All Articles in Issue

Page(s):  21-27

Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 1
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 2
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 3
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 4
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 5
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 6
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 7

Download in electronic PDF format for $75

Abstract:  United States Pharmacopeia Chapter <800>, which became effective on December 1, 2019, addresses handling of hazardous drugs in facilities that make compounded preparations. The Chapter includes minimum facility, engineering controls, personal protective equipment, and other requirements under which all hazardous drugs must be handled. For certain hazardous drugs, an assessment of risk may be performed to determine alternative containment strategies or work practices. This article addresses the legal enforceability of Unites States Pharmacopeia Chapter <800>, how to determine whether a drug is eligible for an assessment of risk, and details important considerations when performing assessments of risk.

Related Keywords: United States Pharmacopeia Chapter <800>, USP, risk assessment, hazardous drugs, engineering controls, drug exposures, enforcement, antineoplastic drugs, reproductive hazardous drugs, NIOSH, OSHA, handling requirements, standard operating procedure, SOP

Related Categories: BUSINESS, LEGAL, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS, PROFESSIONAL ISSUES, HAZARDOUS DRUGS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk
Cabaleiro Joe
Jan/Feb 2020
Pg. 21-27

PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
Sep/Oct 2021
Pg. 356

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
Mar/Apr 2020
Pg. 92

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
May/Jun 2017
Pg. 180

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
May/Jun 2020
Pg. 180

Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
Mar/Apr 2021
Pg. 115-124

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2007
Pg. 404-410

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr
, Okeke Claudia C
Jan/Feb 2009
Pg. 56-62

Change Is In the Air: What You Need to Know About Pharmacy Ventilation Under United States Pharmacopeia <800>
Laniewicz Cheryl
Jul/Aug 2017
Pg. 271-274

How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
May/Jun 2019
Pg. 182-186

PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 92

Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
Mar/Apr 2012
Pg. 146-150

Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal
, Rios GL Quito
Sep/Oct 2022
Pg. 358-362

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
Mar/Apr 2014
Pg. 94-99

Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Hutson Chad
, Day A J
Nov/Dec 2019
Pg. 511-518

Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Kupiec Thomas C
Sep/Oct 2007
Pg. 400-403

Return to Top